Published in TB and Outbreaks Week, May 15th, 2001
M. Jertborn and colleagues at Gothenburg University, Sweden, studied the immunogenicity of different preparations of an oral inactivated enterotoxigenic E. coli (ETEC) vaccine consisting of recombinant cholera toxin B (CTB) subunit and various amounts of formalin-killed whole bacteria expressing the most prevalent colonization factor antigens (CFAs).
The majority of Swedish volunteers, who had not been previously exposed to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week